Pan-tissue mitochondrial phenotyping reveals lower OXPHOS expression and function across cancer types
Abstract Targeting mitochondrial oxidative phosphorylation (OXPHOS) to treat cancer has been hampered due to serious side-effects potentially arising from the inability to discriminate between non-cancerous and cancerous mitochondria. Herein, comprehensive mitochondrial phenotyping was leveraged to...
| Published in: | Scientific Reports |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2023-10-01
|
| Online Access: | https://doi.org/10.1038/s41598-023-43963-5 |
